Is closer linkage between systemic lupus erythematosus and anti-double-stranded DNA antibodies a desirable and attainable goal?

Hans C. Nossent, Ole Petter Rekvig

Research output: Contribution to journalArticlepeer-review

18 Citations (Scopus)

Abstract

The anti-double-stranded DNA (anti-dsDNA) antibody test incorporated in the 1982 revised American College of Rheumatology criteria for the classification of systemic lupus erythematosus needs updating to reflect current insights and technical achievements, including allowance for the presence of nonpathogenic anti-dsDNA antibodies. As we need to develop at least some measure of pathogenicity of anti-dsDNA antibodies, we propose that initial anti-dsDNA antibody screening is done by sensitive ELISA and supplemented by more stringent assays. Simultaneously the relevance of anti-dsDNA antibody presence needs to be restricted to clinical manifestations, thought to be caused by anti-dsDNA antibody and within an appropriate time frame.

Original languageEnglish
Pages (from-to)85-87
Number of pages3
JournalArthritis Research and Therapy
Volume7
Issue number2
DOIs
Publication statusPublished - Apr 2005
Externally publishedYes

Fingerprint

Dive into the research topics of 'Is closer linkage between systemic lupus erythematosus and anti-double-stranded DNA antibodies a desirable and attainable goal?'. Together they form a unique fingerprint.

Cite this